Tower Research Capital (TRC)’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.49K Sell
3,323
-1,788
-35% -$1.81K ﹤0.01% 4741
2026
Q2
$3.06K Buy
5,111
+1,847
+57% +$1.77K ﹤0.01% 4578
2026
Q1
$4.34K Sell
3,264
-1,734
-35% -$2.2K ﹤0.01% 4206
2025
Q4
$5.55K Sell
4,998
-1,846
-27% -$3.31K ﹤0.01% 4114
2025
Q3
$14.2K Buy
6,844
+3,789
+124% +$10.6K ﹤0.01% 3621
2025
Q2
$5.99K Buy
+3,055
New +$5.56K ﹤0.01% 4135
2024
Q4
– Sell
-1,592
Closed -$4.73K – 5715
2024
Q3
$4.73K Sell
1,592
-383
-19% -$1.13K ﹤0.01% 4438
2024
Q2
$6.18K Sell
1,975
-4,940
-71% -$17.1K ﹤0.01% 4610
2024
Q1
$36.2K Buy
6,915
+4,081
+144% +$16.8K ﹤0.01% 2495
2023
Q4
$7K Sell
2,834
-2,239
-44% -$4.86K ﹤0.01% 4676
2023
Q3
$11.3K Buy
5,073
+3,506
+224% +$12.6K ﹤0.01% 4008
2023
Q2
$8.35K Sell
1,567
-113
-7% -$724 ﹤0.01% 4442
2023
Q1
$10K Sell
1,680
-45
-3% -$362 ﹤0.01% 4332
2022
Q4
$22K Buy
1,725
+1,110
+180% +$20.5K ﹤0.01% 3033
2022
Q3
$14K Sell
615
-894
-59% -$27.1K ﹤0.01% 4206
2022
Q2
$51K Buy
1,509
+1,219
+420% +$99K ﹤0.01% 2854
2022
Q1
$25K Buy
+290
New +$17.4K ﹤0.01% 3319
2021
Q3
– Sell
-52
Closed -$5K – 5795
2021
Q2
$5K Sell
52
-19
-27% -$1.92K ﹤0.01% 4692
2021
Q1
$7K Buy
71
+51
+255% +$5.23K ﹤0.01% 4515
2020
Q4
$2K Buy
+20
New +$2.13K ﹤0.01% 4870
2020
Q3
– Sell
-112
Closed -$11K – 4834
2020
Q2
$11K Buy
+112
New +$11.1K ﹤0.01% 3959

Other funds holding CELU

Tower Research Capital (TRC)'s CELU Position: Q3 2026 in Review

Tower Research Capital (TRC) reduced its Celularity (CELU) stake by 35% in Q3 2026, selling an estimated $1.81K and leaving 3,323 shares worth $4.49K. The position accounts for ﹤0.01% of the portfolio, ranked #4741.

Tower Research Capital (TRC) first reported a position in CELU in Q2 2020 and has held it in 21 quarters since. The position peaked at $51K in Q2 2022. 33 funds tracked by Wall St. Rank hold CELU as of Q3 2026.

  • Tower Research Capital (TRC) held 3,323 shares of Celularity worth $4.49K as of Q3 2026.
  • Tower Research Capital (TRC) sold 1,788 Celularity shares in Q3 2026, an estimated $1.81K.
  • Celularity made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4741 holding.
  • Tower Research Capital (TRC) first reported a position in Celularity in Q2 2020 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s Celularity position peaked at $51K in Q2 2022.
  • 33 funds tracked by Wall St. Rank held Celularity as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.